Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 1

Status

Completed 13Recruiting 6Unknown 3Withdrawn 1Terminated 1Enrolling by invitation 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Recurrence 3Neoplasms 3Stomach Neoplasms 2Sarcoma 2Prostatic Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Glioblastoma 2Breast Neoplasms 2Advanced Solid Tumor 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Rhabdomyosarcoma 1Prostatic Neoplasms, Castration-Resistant 1Nevus 1Neurofibromatosis 1 1Neurofibroma 1Nervous System Neoplasms 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Lymphatic Metastasis 1Head and Neck Neoplasms 1HER2-positive Advanced Solid Tumor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Enrolling by invitation × Adenoviridae Infections × Clear all
NCT06215846 2025-11-26

A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Malignant Solid Tumors

Beijing Bio-Targeting Therapeutics Technology Co., Ltd

Phase 1 Enrolling by invitation
12 enrolled

Adenoviridae Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡